DXCM vs ALGN — Key Metrics
| Metric | DXCM (DEXCOM INC) | ALGN (ALIGN TECHNOLOGY INC) |
|---|---|---|
| Price | 82.52 | 163.96 |
| Market Cap | 30.78 Billion | 11.56 Billion |
| P/E (TTM) | 31.86 | 23.83 |
| P/B (Quarterly) | 11.758 | 2.7 |
| P/S (TTM) | 6.03 | 2.78 |
| Net Profit Margin (TTM) | 19.4 | 11.8 |
| Gross Margin (TTM) | 63.4 | 69.1 |
| ROE (TTM) | 36.5 | 11.8 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: ALGN.
Financial Metrics
| DXCM | Metrics | ALGN |
|---|---|---|
| $82.52 | Price | $163.96 |
| — | Market Capitalization | — |
| 31.86 | Price to Earnings Ratio | 23.83 |
| 6.03 | Price to Sales | 2.78 |
| 28.02 | Price to FCF Ratio | 17.93 |
| 9.51 | Price to Gross Profit | 4.02 |
| 50.61 | Price to R&D | 30.61 |
| 7.86 | Price to Current Assets | 4.24 |
DXCM vs ALGN at a glance
Dexcom INC (DXCM) and Align Technology INC (ALGN) are both Medical Devices companies in the Healthcare sector. DXCM is the larger, at $30.8 billion in market value against $11.6 billion for ALGN, about 2.7 times the size.
On trailing-twelve-month figures, DXCM trades at 31.9 times trailing earnings and ALGN at 23.8; net profit margins are 19.4% and 11.8%.
The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.